Guardant Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Guardant Health 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GH

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. 

CEO
AmirAli H. Talasaz
CEOAmirAli H. Talasaz
Employees
2,021
Employees2,021
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2011
Founded2011
Employees
2,021
Employees2,021

GH Key Statistics

Market cap
12.19B
Market cap12.19B
Price-Earnings ratio
-30.45
Price-Earnings ratio-30.45
Dividend yield
Dividend yield
Average volume
4.45M
Average volume4.45M
High today
$98.05
High today$98.05
Low today
$94.04
Low today$94.04
Open price
$97.03
Open price$97.03
Volume
752.19K
Volume752.19K
52 Week high
$101.57
52 Week high$101.57
52 Week low
$28.45
52 Week low$28.45

Stock Snapshot

With a market cap of 12.19B, Guardant Health(GH) trades at $94.11. The stock has a price-to-earnings ratio of -30.45.

During the trading session on 2025-11-13, Guardant Health(GH) shares reached a daily high of $98.05 and a low of $94.04. At a current price of $94.11, the stock is +0.1% higher than the low and still -4.0% under the high.

Trading volume for Guardant Health(GH) stock has reached 752.19K, versus its average volume of 4.45M.

Over the past 52 weeks, Guardant Health(GH) stock has traded between a high of $101.57 and a low of $28.45.

Over the past 52 weeks, Guardant Health(GH) stock has traded between a high of $101.57 and a low of $28.45.

GH News

Simply Wall St 1d
Don't Ignore The Insider Selling In Guardant Health

Some Guardant Health, Inc. ( ) shareholders may be a little concerned to see that the Chief Legal Officer & Corporate Secretary, John Saia, recently sold a subs...

Don't Ignore The Insider Selling In Guardant Health

Analyst ratings

88%

of 26 ratings
Buy
88.5%
Hold
7.7%
Sell
3.8%

People also own

Based on the portfolios of people who own GH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.